Osteitis Fibrosa Is Mediated by Platelet-Derived Growth Factor-A Via a Phosphoinositide 3-Kinase-Dependent Signaling Pathway in a Rat Model for Chronic Hyperparathyroidism
| Autor: | Brett K. Palama, Avudaiappan Maran, Sutada Lotinun, M. Zhang, Russell T. Turner, Urszula T. Iwaniec, Malcolm B. Lowry, Alexey A. Leontovich, Kristen L. Shogren, Kevin Marley |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Platelet-derived growth factor Osteitis Fibrosa Cystica Parathyroid hormone Lysyl oxidase Article Rats Sprague-Dawley Wortmannin Phosphatidylinositol 3-Kinases chemistry.chemical_compound Endocrinology Internal medicine medicine Animals Cluster Analysis Oligonucleotide Array Sequence Analysis Platelet-Derived Growth Factor Regulation of gene expression Phosphoinositide 3-kinase biology Gene Expression Profiling Hyperparathyroidism Rats Disease Models Animal Gene Expression Regulation chemistry Parathyroid Hormone Chronic Disease biology.protein Female Signal transduction Platelet-derived growth factor receptor Signal Transduction |
| Zdroj: | Endocrinology. 149:5735-5746 |
| ISSN: | 1945-7170 0013-7227 |
| DOI: | 10.1210/en.2008-0134 |
| Popis: | Abnormal secretion of PTH by the parathyroid glands contributes to a variety of common skeletal disorders. Prior studies implicate platelet-derived growth factor-A (PDGF-A) as an important mediator of selective PTH actions on bone. The present studies used targeted gene profiling and small-molecule antagonists directed against candidate gene products to elucidate the roles of specific PTH-regulated genes and signaling pathways. A group of 29 genes in rats continuously infused with PTH and cotreated with the PDGF receptor antagonist trapidil were differentially expressed compared with PTH treatment alone. Several of the identified genes were functionally clustered as regulators of fibroblast differentiation and extracellular matrix modeling, including the matrix cross-linking enzyme lysyl oxidase (LOX). Treatment with β-aminopropionitrile, an irreversible inhibitor of LOX activity, dramatically reduced diffuse mineralization but had no effect on PTH-induced fibrosis. In contrast, the receptor tyrosine kinase inhibitor Gleevec and the phosphoinositide 3-kinase inhibitor wortmannin each reduced bone marrow fibrosis. In summary, the present studies support the hypotheses that PTH-induced bone marrow fibrosis is mediated by PDGF-A via a phosphoinositide 3-kinase-dependent signaling pathway and that increased LOX gene expression plays a key role in abnormal mineralization, a hallmark of chronic hyperparathyroidism. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|